The Aneufast™ QF-PCR diagnostic testing Kit is a molecular diagnostic assay used for rapid prenatal screening for and diagnosis of Trisomy 21 (down syndrome) , Trisomy 18(Edwards syndrome), Trisomy 13 (Patau syndrome) and Sex chromosomes Aneuploidies.
Aneufast QF-PCR Aneuploidy Diagnostic Testing Kit (25 rxn)
Detection of aneuploidies involving chromosomes X, Y, 21, 18 and 13
The Aneufast™ aneuploidy diagnostic testing kit contains a total of 35 markers in six ready to use mixes. The markers amplify the gender determining sequences Amelogenin-SRY and selected STRs. In approximately 96 percent of the cases a definitive result is given by two multiplex QF-PCR amplifications (S1 and S2) of 21 markers. The two assays are designed to be analysed in a single electrophoresis, therefore increasing the sample throughput.
Markers included in Aneufast™ have been extensively validated and applied on over 30,000 clinical specimens.
Additional data regarding the markers included in Aneufast™ are retrievable in public databases, which are accessible worldwide.